A leading think-tank has warned the Government’s plans could potentially add too much fuel to the economy and lead to another bust.

Pharmaceutical process development roles have doubled in Ireland thanks to shifts in US tax policies and other external drivers, according to NUI Maynooth economic geographer Chris van Egeraat.

SOME €19 billion of Irish pharmaceutical exports may be impacted by the expiration of patents on a number of blockbuster medicines produced here.